A study analysing distribution of anti-factor Xa activity value, PT and APTT at peak and trough times in patients with direct anti-factor Xa inhibitors
Latest Information Update: 06 Nov 2020
At a glance
- Drugs Apixaban (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Blood coagulation disorders
- Focus Therapeutic Use
- 06 Nov 2020 New trial record